Study Stopped
never started
Phenotyping Acute Pain for Discovery Research and Directed Therapeutics
1 other identifier
observational
N/A
1 country
1
Brief Summary
The goal of the current study is to combine existing and new tools for quantifying patient self-report to characterize changes in acute pain. The ability to quantitatively measure self-report provides behavioral pain phenotypes that can serve as the basis for clustering patients into sub-groups based on their self-report of their symptoms, eliminating observer based perceptions of patients' pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2014
CompletedFirst Posted
Study publicly available on registry
December 23, 2014
CompletedStudy Start
First participant enrolled
February 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2018
CompletedFebruary 23, 2018
February 1, 2018
Same day
December 10, 2014
February 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
characterize changes in acute pain
The goal of the current study is to combine existing and new tools for quantifying patient self-report to characterize changes in acute pain
48 hours
Study Arms (1)
open label
After the surgery and the onset of moderate-severe pain, QST and PROMIS questionnaires will be repeated. Throughout these procedures, patients will rate their pain perception using a numeric rating scale. Approximately 2-3 hours after surgery at the onset of moderate pain, the rescue analgesic (toradol) will be administered via intramuscular injection. Again, QST and PROMIS protocols will be repeated after the drug is given and when patients report pain relief. A standard naproxen dose of 500 mg will be given to patients upon leaving the clinic and they will be instructed to take one pill orally each day before returning for evaluation after 48 hours.
Interventions
The deep phenotyping of acute pain will be conducted using the oral surgery model. Before surgery, subjects will undergo QST and answer short-form questionnaires related to pain and activities of daily living.
Eligibility Criteria
Male or females over 18 years of age
You may qualify if:
- Male and female patients aged 18 and older willing to undergo clinically indicated non-emergent oral surgery for the removal of impacted third molars with local anesthesia
- Indicated for the removal of third molars, at least a minimum of one partial-bony impacted third molar, with a total difficulty score total of not less than 4\*
- Communicate in spoken and written English
- Willing to undergo research observation for 4 hours postoperatively and 48 hour follow up visit
- In good health with an ASA status of 1 or 2 by self report and review of medical history
- Self-report of moderate or severe pain on a categorical scale with a minimum of 4 out of 10 on the numerical rating scale following the offset of local anesthesia
- =erupted, 2=soft tissue impaction, 3=partial bony impaction, 4=full bony impaction, 5 = unusual surgical difficulty
You may not qualify if:
- Current or history of mental disorder or substance abuse
- Allergy to aspirin, NSAIDS, or sulfonamide
- Pregnant and/or nursing
- History of peptic ulcers and/or GI bleeding
- Concurrent use of agents which may obscure pain report, e.g., alcohol, opioids, benzodiazepines, and depressants, etc
- Chronic use of medications confounding assessment of the inflammatory response or analgesia, e.g., antihistamines, NSAIDS, steroids, antidepressants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Dental Medicine At East Carolina University
Greenville, North Carolina, 27834, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raymond Dionne, DDS
School of Dental Medicine at East Carolina University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Raymond A. Dionne, DDS, PhD Research Professor Department of Pharmacology & Toxicology Brody School of Medicine Department of Foundational Sciences School of Dental Medicine East Carolina University Greenville, NC 27834-4354
Study Record Dates
First Submitted
December 10, 2014
First Posted
December 23, 2014
Study Start
February 21, 2018
Primary Completion
February 21, 2018
Study Completion
February 21, 2018
Last Updated
February 23, 2018
Record last verified: 2018-02